Role of β Adrenergic Receptor Polymorphisms in Heart Failure: Systematic Review and Meta-Analysis
- 1 January 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 10 (1) , 3-13
Abstract
Heart Failure (HF) is a common disorder associated with substantial morbidity and mortality. β adrenergic receptors (βAR) are the primary pathway through which cardiac function is influenced. Chronic β1AR activation is implicated in the pathogenesis of HF and βAR blockade improves survival in left ventricular systolic dysfunction. Common functional polymorphisms in β adrenergic receptor genes (ADRB) have been associated with HF phenotypes, and with pharmacogenetic interaction with β adrenergic receptor blockers (β blockers). However, these associations have not been consistently replicated. The evidence for ADRB variant involvement in pathogenesis, progression and response to β blockers in HF is reviewed. In addition, a meta-analysis of three studies analysing the effect of ADRB1 Arg389Gly polymorphism on left ventricular remodelling with the use of β blockers, demonstrating a 5% improvement in left ventricular ejection fraction in Arg389 homozygotes, is presented. There is now accumulating molecular evidence for a different functional response to β blockers associated with this polymorphism. In the future, confirmed genotypic associations may enable patients to be identified who are either at greater risk of developing HF, whose HF may rapidly progress, or who are unlikely to benefit from β blockers, and such patients may benefit from targeted aggressive therapy.Keywords
This publication has 80 references indexed in Scilit:
- Real-time optical recording of β1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilolJournal of Clinical Investigation, 2007
- A polymorphism within a conserved β1-adrenergic receptor motif alters cardiac function and β-blocker response in human heart failureProceedings of the National Academy of Sciences, 2006
- The Arg389Gly ??1-adrenoceptor gene polymorphism determines contractile response to catecholaminesPharmacogenetics, 2004
- Functional responses of human ??1 adrenoceptors with defined haplotypes for the common 389R>G and 49S>G polymorphismsPharmacogenetics, 2004
- The Myocardium-protective Gly-49 Variant of the β1-Adrenergic Receptor Exhibits Constitutive Activity and Increased Desensitization and Down-regulationJournal of Biological Chemistry, 2002
- The Arg 389 Gly β1-adrenergic receptor gene polymorphism and human fat cell lipolysisInternational Journal of Obesity, 2001
- Characterization of a Unique Genetic Variant in the β1-adrenoceptor Gene and Evaluation of its Role in Idiopathic Dilated CardiomyopathyJournal of Molecular and Cellular Cardiology, 1999
- Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli: roles of cyclic nucleotides, calcium, protein kinases and phosphatases and depolarizationMolecular and Cellular Biochemistry, 1995
- Prostaglandins in Severe Congestive Heart FailureNew England Journal of Medicine, 1984
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982